Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa

Autores:
Parra-López, Carlos
Marchena-Mendoza, Darnel
Delgado, Gabriela
Pachón, Alejandro
Melo, Carlos
Cómbita, Alba Lucía
Vargas, Luis Eduardo
Patarroyo, Manuel Elkin
Tipo de recurso:
Article of journal
Fecha de publicación:
2004
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/2269
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/2269
https://doi.org/10.31260/RepertMedCir.v13.n4.2004.362
Palabra clave:
Rights
openAccess
License
Fundación Universitaria de Ciencias de la Salud FUCS - 0
id FUCS2_b0dd057a75c596c6aee79d1b82c65b09
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/2269
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
dc.title.translated.eng.fl_str_mv Detection of specific memory lymphocytes against HPV-16 in men and women with active sexual life
title Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
spellingShingle Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
title_short Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
title_full Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
title_fullStr Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
title_full_unstemmed Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
title_sort Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activa
dc.creator.fl_str_mv Parra-López, Carlos
Marchena-Mendoza, Darnel
Delgado, Gabriela
Pachón, Alejandro
Melo, Carlos
Cómbita, Alba Lucía
Vargas, Luis Eduardo
Patarroyo, Manuel Elkin
dc.contributor.author.spa.fl_str_mv Parra-López, Carlos
Marchena-Mendoza, Darnel
Delgado, Gabriela
Pachón, Alejandro
Melo, Carlos
Cómbita, Alba Lucía
Vargas, Luis Eduardo
Patarroyo, Manuel Elkin
publishDate 2004
dc.date.accessioned.none.fl_str_mv 2004-12-01 00:00:00
2022-02-21T20:35:47Z
dc.date.issued.none.fl_str_mv 2004-12-01
dc.date.available.none.fl_str_mv 2004-12-01 00:00:00
2022-02-21T20:35:47Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.31260/RepertMedCir.v13.n4.2004.362
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/2269
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://doi.org/10.31260/RepertMedCir.v13.n4.2004.362
identifier_str_mv 10.31260/RepertMedCir.v13.n4.2004.362
0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/2269
https://doi.org/10.31260/RepertMedCir.v13.n4.2004.362
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev. Cancer 2002; 2 (5):342-50.
Galloway DA. Papillomavirus vaccines in clinical trials. Lancet Infect Dis 2003; 3(8):469-75.
Koutsky LA, Ault KA, Wheeler CM, et al. Proof of Principle Study Investigators. A controlled trial of a humanpapillomavirus type 16 vaccine. N Engl J Med 2002; 347(21):1645-51.
Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med 2004; 55:319- 31. Review.
Pinto LA, Edwards J, Castle PE, et al. Cellular immune responses to human papillomavirus (VPH)-16 Ll in healthy volunteers immunized with recombinant VPH-16 L1 viruslike particles. J Infect Dis 2003; 188(2):327-38.
Finnen RL, Erickson KD, Chen XS, Garcea RL. Interactions between papillomavirus Ll and L2 capsid proteins. J Virol 2003, 77 (8):4818-26.
Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC. Structure of small virus-like particles assembled from the Ll protein ofhuman papillomavirus 16. Mol Cell 2000; 5 (3):557-67.
Carter JJ, Wipf GC, Benki SF, Christensen ND, Galloway DA. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein Ll. J Virol 2003;77 (21):11625-32.
Viscidi RP, Ahdieh-Grant L, Schneider MF, et al. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J. Infect. Dis 2003;188 (12):1834-44.
Vera-Bravo R, Ocampo M, Urquiza M, Garcia JE, et al. Human papillomavirus type 16 and 18 Ll protein peptide binding to VERO and HeLa cells inhibits their VLPs binding. Int J Cancer 2003; 107 (3):416-24.
Christensen ND, Reed CA, Cladel NM, Hall K, Leiserowitz GS. Monoclonal antibodies to VPH-6 L1 virus-like particles identify conformational and linear neutralizing epitops on VPH-11 in addition to type-specific epitopes on VPH-6. Virology 1996; 224 (2):477-86.
Molano M, Posso H, Weiderpass E. et al. VPH Study Group VPH Study. Prevalence and determinants of VPH infection among Colombian women with normal cytology. Br J Cancer 2002; 87 (3):324-33.
Combita AL, Bravo MM, Touze A, Orozco O, Coursaget P. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer. Int J Cancer 2002; 97 (6):796-803.
Delgado Parra-Lopez CA, Vargas LE, et al. Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs). Parasite. Immunol 2003; 25 (4):199-20.
Calvo-Calle JM, Hammer J, Sinigaglia F, Clavijo P, Moya-Castro ZR, Nardin EH. Binding of malaria T cell epitops to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitopes in the Plasmodium falcipamm circumsporozoite protein. J Immunol 1997; 159 (3):1362-73.
Sprent J, Surh CD. T cell memory. Annu. Rev Immunol 2002; 20:551-79.
Reece WH, Pinder M, Gothard PK, et al. ACD4 (+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med 2004;10 (4):406-10.
Stone KM, Karem KL, Stemberg MR, McQuillan GM, Poon AD, Unger ER, Reeves WC. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186 (10):1396-402.
Lenz P, Day PM, Pang YY, Frye SA, Jensen PN, Lowy DR, Schiller JT. Papillomavirus-like particles induce acute activation ofdendritic cells. J Immunol 2001; 166 (9):5346-55.
Vargas LE, Parra CA, Salazar LM, Guzman F, Pinto M, Patarroyo ME. MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem Biophys Res Commun 2003; 307 (1):148-56.
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/362/389
dc.relation.citationedition.spa.fl_str_mv Núm. 4 , Año 2004 : Octubre – Diciembre
dc.relation.citationendpage.none.fl_str_mv 200
dc.relation.citationissue.spa.fl_str_mv 4
dc.relation.citationstartpage.none.fl_str_mv 187
dc.relation.citationvolume.spa.fl_str_mv 13
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv Fundación Universitaria de Ciencias de la Salud FUCS - 0
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Fundación Universitaria de Ciencias de la Salud FUCS - 0
https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/362
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/5481179e-da46-4f97-96ad-ce4416f2f303/download
bitstream.checksum.fl_str_mv fb11e0f28753f1697ea453a2337bceae
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1814355568863739904
spelling Parra-López, Carlos2550079f70eb5b24df136e6404be74b0300Marchena-Mendoza, Darnel8147b175210be05fd5e99a494fc6227e300Delgado, Gabriela525ae6ca864ab5279825d193e058fccc300Pachón, Alejandrocf9ad1e17e1d6494a7e454d1e4b631fd300Melo, Carlos78833e80ffe376f0fb25f9b1d45dfd92300Cómbita, Alba Lucía9e4a9b3b12cf48e8c47be2899c71a5a7300Vargas, Luis Eduardoc3d127e69b97ab13067a25c360102b05300Patarroyo, Manuel Elkin162d8e115d19c694891817f5421f53dd3002004-12-01 00:00:002022-02-21T20:35:47Z2004-12-012004-12-01 00:00:002022-02-21T20:35:47ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/362Detección de linfocitos de memoria específicos contra el VPH-16 en hombres y mujeres con vida sexual activaDetection of specific memory lymphocytes against HPV-16 in men and women with active sexual lifeapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v13.n4.2004.3620121-7372https://repositorio.fucsalud.edu.co/handle/001/22692462-991Xhttps://doi.org/10.31260/RepertMedCir.v13.n4.2004.362spaZur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev. Cancer 2002; 2 (5):342-50.Galloway DA. Papillomavirus vaccines in clinical trials. Lancet Infect Dis 2003; 3(8):469-75.Koutsky LA, Ault KA, Wheeler CM, et al. Proof of Principle Study Investigators. A controlled trial of a humanpapillomavirus type 16 vaccine. N Engl J Med 2002; 347(21):1645-51.Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med 2004; 55:319- 31. Review.Pinto LA, Edwards J, Castle PE, et al. Cellular immune responses to human papillomavirus (VPH)-16 Ll in healthy volunteers immunized with recombinant VPH-16 L1 viruslike particles. J Infect Dis 2003; 188(2):327-38.Finnen RL, Erickson KD, Chen XS, Garcea RL. Interactions between papillomavirus Ll and L2 capsid proteins. J Virol 2003, 77 (8):4818-26.Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC. Structure of small virus-like particles assembled from the Ll protein ofhuman papillomavirus 16. Mol Cell 2000; 5 (3):557-67.Carter JJ, Wipf GC, Benki SF, Christensen ND, Galloway DA. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein Ll. J Virol 2003;77 (21):11625-32.Viscidi RP, Ahdieh-Grant L, Schneider MF, et al. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J. Infect. Dis 2003;188 (12):1834-44.Vera-Bravo R, Ocampo M, Urquiza M, Garcia JE, et al. Human papillomavirus type 16 and 18 Ll protein peptide binding to VERO and HeLa cells inhibits their VLPs binding. Int J Cancer 2003; 107 (3):416-24.Christensen ND, Reed CA, Cladel NM, Hall K, Leiserowitz GS. Monoclonal antibodies to VPH-6 L1 virus-like particles identify conformational and linear neutralizing epitops on VPH-11 in addition to type-specific epitopes on VPH-6. Virology 1996; 224 (2):477-86.Molano M, Posso H, Weiderpass E. et al. VPH Study Group VPH Study. Prevalence and determinants of VPH infection among Colombian women with normal cytology. Br J Cancer 2002; 87 (3):324-33.Combita AL, Bravo MM, Touze A, Orozco O, Coursaget P. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer. Int J Cancer 2002; 97 (6):796-803.Delgado Parra-Lopez CA, Vargas LE, et al. Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs). Parasite. Immunol 2003; 25 (4):199-20.Calvo-Calle JM, Hammer J, Sinigaglia F, Clavijo P, Moya-Castro ZR, Nardin EH. Binding of malaria T cell epitops to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitopes in the Plasmodium falcipamm circumsporozoite protein. J Immunol 1997; 159 (3):1362-73.Sprent J, Surh CD. T cell memory. Annu. Rev Immunol 2002; 20:551-79.Reece WH, Pinder M, Gothard PK, et al. ACD4 (+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med 2004;10 (4):406-10.Stone KM, Karem KL, Stemberg MR, McQuillan GM, Poon AD, Unger ER, Reeves WC. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186 (10):1396-402.Lenz P, Day PM, Pang YY, Frye SA, Jensen PN, Lowy DR, Schiller JT. Papillomavirus-like particles induce acute activation ofdendritic cells. J Immunol 2001; 166 (9):5346-55.Vargas LE, Parra CA, Salazar LM, Guzman F, Pinto M, Patarroyo ME. MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem Biophys Res Commun 2003; 307 (1):148-56.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/362/389Núm. 4 , Año 2004 : Octubre – Diciembre200418713Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2595https://repositorio.fucsalud.edu.co/bitstreams/5481179e-da46-4f97-96ad-ce4416f2f303/downloadfb11e0f28753f1697ea453a2337bceaeMD51001/2269oai:repositorio.fucsalud.edu.co:001/22692024-02-02 13:11:32.346https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co